Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signaling

FASEB Journal

Volumn 27, Issue 2, 2013, Pages 437-445

  Pekcec, Anton ^a   Yigitkanli, Kazim ^a   Jung, Joo Eun ^a   Pallast, Stefanie ^a   Xing, Changhong ^a   Antipenko, Alexander ^b   Minchenko, Maria ^b   Nikolov, Dimitar B ^b   Holman, Theodore R ^c   Lo, Eng H ^a   Van Leyen, Klaus ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

12 HPETE; Axon growth; Cortex; Eicosanoid; Second messenger

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ICOSANOID; ISOENZYME; LIPOXYGENASE; SEMAPHORIN 3A;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CELL; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CORPUS STRIATUM; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPINAL GANGLION;

EID: 84873441307     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-206896     Document Type: Article

References (66)

1. Wang, X., Tsuji, K., Lee, S. R., Ning, M., Furie, K. L., Buchan, A. M., and Lo, E. H. (2004) Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke 35, 2726-2730
2. Mostany, R., Chowdhury, T. G., Johnston, D. G., Portonovo, S. A., Carmichael, S. T., and Portera-Cailliau, C. (2010) Local hemodynamics dictate long-term dendritic plasticity in periinfarct cortex. J. Neurosci. 30, 14116-14126
3. Dawson, T. M., and Dawson, V. L. (2006) Taming the clot-buster tPA. Nat. Med. 12, 993-994
4. Willmot, M., Gray, L., Gibson, C., Murphy, S., and Bath, P. M. (2005) A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide 12, 141-149
5. Moskowitz, M. A., Lo, E. H., and Iadecola, C. (2010) The science of stroke: mechanisms in search of treatments. Neuron 67, 181-198
6. Xiong, Y., Mahmood, A., and Chopp, M. (2010) Angiogenesis, neurogenesis and brain recovery of function following injury. Curr. Opin. Investig. Drugs 11, 298-308
7. Hoang, S., Liauw, J., Choi, M., Guzman, R. G., and Steinberg, G. K. (2009) Netrin-4 enhances angiogenesis and neurologic outcome after cerebral ischemia. J. Cereb. Blood Flow Metab. 29, 385-397
8. Kolodkin, A. L., Matthes, D. J., and Goodman, C. S. (1993) The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 75, 1389-1399
9. Luo, Y., Raible, D., and Raper, J. A. (1993) Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75, 217-227
10. Zlokovic, B. V. (2010) Neurodegeneration and the neurovascular unit. Nat. Med. 16, 1370-1371
11. Lo, E. H., and Rosenberg, G. A. (2009) The neurovascular unit in health and disease: introduction. Stroke 40, S2-3
12. Hara, M. R., Thomas, B., Cascio, M. B., Bae, B. I., Hester, L. D., Dawson, V. L., Dawson, T. M., Sawa, A., and Snyder, S. H. (2006) Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proc. Natl. Acad. Sci. U. S. A. 103, 3887-3889
13. Hayashi, T., Noshita, N., Sugawara, T., and Chan, P. H. (2003) Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J. Cereb. Blood. Flow Metab. 23, 166-180
14. He, Z., and Koprivica, V. (2004) The Nogo signaling pathway for regeneration block. Annu. Rev. Neurosci. 27, 341-368
15. Lee, J. K., Kim, J. E., Sivula, M., and Strittmatter, S. M. (2004) Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J. Neurosci. 24, 6209-6217
16. Wiessner, C., Bareyre, F. M., Allegrini, P. R., Mir, A. K., Frentzel, S., Zurini, M., Schnell, L., Oertle, T., and Schwab, M. E. (2003) Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J. Cereb. Blood Flow Metab. 23, 154-165
17. Jiang, S. X., Whitehead, S., Aylsworth, A., Slinn, J., Zurakowski, B., Chan, K., Li, J., and Hou, S. T. (2010) Neuropilin 1 directly interacts with Fer kinase to mediate semaphorin 3A-induced death of cortical neurons. J. Biol. Chem. 285, 9908-9918
18. He, Z., and Tessier-Lavigne, M. (1997) Neuropilin is a receptor for the axonal chemorepellent semaphorin III. Cell 90, 739-751
19. Kolodkin, A. L., Levengood, D. V., Rowe, E. G., Tai, Y. T., Giger, R. J., and Ginty, D. D. (1997) Neuropilin is a semaphorin III receptor. Cell 90, 753-762
20. Tamagnone, L., Artigiani, S., Chen, H., He, Z., Ming, G. I., Song, H., Chedotal, A., Winberg, M. L., Goodman, C. S., Poo, M., Tessier-Lavigne, M., and Comoglio, P. M. (1999) Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99, 71-80
21. Takahashi, T., Fournier, A., Nakamura, F., Wang, L. H., Murakami, Y., Kalb, R. G., Fujisawa, H., and Strittmatter, S. M. (1999) Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 99, 59-69
22. Mikule, K., Gatlin, J. C., de la Houssaye, B. A., and Pfenninger, K. H. (2002) Growth cone collapse induced by semaphorin 3A requires 12/15-lipoxygenase. J. Neurosci. 22, 4932-4941
23. Mikule, K., Sunpaweravong, S., Gatlin, J. C., and Pfenninger, K. H. (2003) Eicosanoid activation of protein kinase C epsilon: involvement in growth cone repellent signaling. J. Biol. Chem. 278, 21168-21177
24. Sanford, S. D., Yun, B. G., Leslie, C. C., Murphy, R. C., and Pfenninger, K. H. (2012) Group IVA phospholipase A(2) is necessary for growth cone repulsion and collapse. J. Neurochem. 120, 974-984
25. Kruger, R. P., Aurandt, J., and Guan, K. L. (2005) Semaphorins command cells to move. Nat. Rev. Mol. Cell Biol. 6, 789-800
26. Liu, B. P., and Strittmatter, S. M. (2001) Semaphorin-mediated axonal guidance via Rho-related G proteins. Curr. Opin. Cell Biol. 13, 619-626
27. Jin, Z., and Strittmatter, S. M. (1997) Rac1 mediates collapsin-1-induced growth cone collapse. J. Neurosci. 17, 6256-6263
28. Hung, R. J., Yazdani, U., Yoon, J., Wu, H., Yang, T., Gupta, N., Huang, Z., van Berkel, W. J., and Terman, J. R. (2010) Mical links semaphorins to F-actin disassembly. Nature 463, 823-827
29. Barberis, D., Artigiani, S., Casazza, A., Corso, S., Giordano, S., Love, C. A., Jones, E. Y., Comoglio, P. M., and Tamagnone, L. (2004) Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility. FASEB J. 18, 592-594
30. Kaneko, S., Iwanami, A., Nakamura, M., Kishino, A., Kikuchi, K., Shibata, S., Okano, H. J., Ikegami, T., Moriya, A., Konishi, O., Nakayama, C., Kumagai, K., Kimura, T., Sato, Y., Goshima, Y., Taniguchi, M., Ito, M., He, Z., Toyama, Y., and Okano, H. (2006) A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat. Med. 12, 1380-1389
31. Williams, G., Eickholt, B. J., Maison, P., Prinjha, R., Walsh, F. S., and Doherty, P. (2005) A complementary peptide approach applied to the design of novel semaphorin/neuropilin antagonists. J. Neurochem. 92, 1180-1190
32. Montolio, M., Messeguer, J., Masip, I., Guijarro, P., Gavin, R., Antonio Del Rio, J., Messeguer, A., and Soriano, E. (2009) A semaphorin 3A inhibitor blocks axonal chemorepulsion and enhances axon regeneration. Chem. Biol. 16, 691-701
33. Antipenko, A., Himanen, J. P., van Leyen, K., Nardi-Dei, V., Lesniak, J., Barton, W. A., Rajashankar, K. R., Lu, M., Hoemme, C., Puschel, A. W., and Nikolov, D. B. (2003) Structure of the semaphorin-3A receptor binding module. Neuron 39, 589-598
34. Willmot, M., Gibson, C., Gray, L., Murphy, S., and Bath, P. (2005) Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic. Biol. Med. 39, 412-425
35. Simao, F., Pagnussat, A. S., Seo, J. H., Navaratna, D., Leung, W., Lok, J., Guo, S., Waeber, C., Salbego, C. G., and Lo, E. H. (2012) Pro-angiogenic effects of resveratrol in brain endothelial cells: nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases. J Cereb Blood Flow Metab 32, 884-895
36. Xing, C., Lee, S., Kim, W. J., Wang, H., Yang, Y. G., Ning, M., Wang, X., and Lo, E. H. (2009) Neurovascular effects of CD47 signaling: promotion of cell death, inflammation, and suppression of angiogenesis in brain endothelial cells in vitro. J. Neurosci. Res. 87, 2571-2577
37. Pallast, S., Arai, K., Pekcec, A., Yigitkanli, K., Yu, Z., Wang, X., Lo, E. H., and van Leyen, K. (2010) Increased nuclear apoptosisinducing factor after transient focal ischemia: a 12/15-lipoxygenase-dependent organelle damage pathway. J. Cereb. Blood Flow Metab. 30, 1157-1167
38. Van Leyen, K., Arai, K., Jin, G., Kenyon, V., Gerstner, B., Rosenberg, P. A., Holman, T. R., and Lo, E. H. (2008) Novel lipoxygenase inhibitors as neuroprotective reagents. J. Neurosci. Res. 86, 904-909
39. Foerch, C., Arai, K., Jin, G., Park, K. P., Pallast, S., van Leyen, K., and Lo, E. H. (2008) Experimental model of warfarin-associated intracerebral hemorrhage. Stroke 39, 3397-3404
40. Yigitkanli, K., Pekcec, A., Karatas, H., Pallast, S., Mandeville, E., Joshi, N., Smirnova, N., Gazaryan, I., Ratan, R. R., Witztum, J. L., Montaner, J., Holman, T. R., Lo, E. H., and van Leyen, K. (2012) Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke. Ann. Neurol. In press; doi: 10.1002/ana.23734
41. Shirvan, A., Ziv, I., Fleminger, G., Shina, R., He, Z., Brudo, I., Melamed, E., and Barzilai, A. (1999) Semaphorins as mediators of neuronal apoptosis. J. Neurochem. 73, 961-971
42. Piomelli, D., Wang, J. K., Sihra, T. S., Nairn, A. C., Czernik, A. J., and Greengard, P. (1989) Inhibition of Ca2+/calmodulin-dependent protein kinase II by arachidonic acid and its metabolites. Proc. Natl. Acad. Sci. U. S. A. 86, 8550-8554
43. Piomelli, D., Volterra, A., Dale, N., Siegelbaum, S. A., Kandel, E. R., Schwartz, J. H., and Belardetti, F. (1987) Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells. Nature 328, 38-43
44. Nishiyama, M., Hoshino, A., Tsai, L., Henley, J. R., Goshima, Y., Tessier-Lavigne, M., Poo, M. M., and Hong, K. (2003) Cyclic AMP/GMP-dependent modulation of Ca2+ channels sets the polarity of nerve growth-cone turning. Nature 423, 990-995
45. Clarkson, A. N., and Carmichael, S. T. (2009) Cortical excitability and post-stroke recovery. Biochem. Soc. Trans. 37, 1412-1414
46. van Leyen, K., Kim, H. Y., Lee, S. R., Jin, G., Arai, K., and Lo, E. H. (2006) Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 37, 3014-3018
47. Goodman, C. S. (1996) Mechanisms and molecules that control growth cone guidance. Annu. Rev. Neurosci. 19, 341-377
48. Serini, G., Valdembri, D., Zanivan, S., Morterra, G., Burkhardt, C., Caccavari, F., Zammataro, L., Primo, L., Tamagnone, L., Logan, M., Tessier-Lavigne, M., Taniguchi, M., Puschel, A. W., and Bussolino, F. (2003) Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 424, 391-397
49. Neufeld, G., Cohen, T., Shraga, N., Lange, T., Kessler, O., and Herzog, Y. (2002) The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc. Med. 12, 13-19
50. Neufeld, G., and Kessler, O. (2008) The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat. Rev. Cancer 8, 632-645
51. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745
52. Zhang, Z. G., Tsang, W., Zhang, L., Powers, C., and Chopp, M. (2001) Up-regulation of neuropilin-1 in neovasculature after focal cerebral ischemia in the adult rat. J. Cereb. Blood Flow Metab. 21, 541-549
53. Pasterkamp, R. J., Giger, R. J., Ruitenberg, M. J., Holtmaat, A. J., De Wit, J., De Winter, F., and Verhaagen, J. (1999) Expression of the gene encoding the chemorepellent semaphorin III is induced in the fibroblast component of neural scar tissue formed following injuries of adult but not neonatal CNS. Mol. Cell. Neurosci. 13, 143-166
54. Jin, G., Arai, K., Murata, Y., Wang, S., Stins, M. F., Lo, E. H., and van Leyen, K. (2008) Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia. Stroke 39, 2538-2543
55. Nishiyama, M., Okamoto, H., Watanabe, T., Hori, T., Sasaki, T., Kirino, T., and Shimizu, T. (1998) Endothelium is required for 12- hydroperoxyeicosatetraenoic acid-induced vasoconstriction. Eur. J. Pharmacol. 341, 57-63
56. Carmichael, S. T., Archibeque, I., Luke, L., Nolan, T., Momiy, J., and Li, S. (2005) Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex. Exp. Neurol. 193, 291-311
57. Hou, S. T., Keklikian, A., Slinn, J., O'Hare, M., Jiang, S. X., and Aylsworth, A. (2008) Sustained up-regulation of semaphorin 3A, Neuropilin1, and doublecortin expression in ischemic mouse brain during long-term recovery. Biochem. Biophys. Res. Commun. 367, 109-115
58. Stroemer, R. P., and Rothwell, N. J. (1998) Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1 in the rat. J. Cereb. Blood Flow Metab. 18, 833-839
59. Grundy, R. I., Rothwell, N. J., and Allan, S. M. (2002) Sitespecific actions of interleukin-1 on excitotoxic cell death in the rat striatum. Brain Res. 926, 142-148
60. Kunz, A., Abe, T., Hochrainer, K., Shimamura, M., Anrather, J., Racchumi, G., Zhou, P., and Iadecola, C. (2008) Nuclear factorB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion. J. Neurosci. 28, 1649-1658
61. Bazan, N. G., Marcheselli, V. L., and Cole-Edwards, K. (2005) Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. Ann. N. Y. Acad. Sci. 1053, 137-147
62. Belayev, L., Khoutorova, L., Atkins, K. D., and Bazan, N. G. (2009) Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke 40, 3121-3126
63. Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., and Bazan, N. G. (2003) Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and proinflammatory gene expression. J. Biol. Chem. 278, 43807-43817
64. Nie, D., Tang, K., Diglio, C., and Honn, K. V. (2000) Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase. Blood 95, 2304-2311
65. Nie, D., Krishnamoorthy, S., Jin, R., Tang, K., Chen, Y., Qiao, Y., Zacharek, A., Guo, Y., Milanini, J., Pages, G., and Honn, K. V. (2006) Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells. J. Biol. Chem. 281, 18601-18609
66. Zafiriou, M. P., Deva, R., Ciccoli, R., Siafaka-Kapadai, A., and Nigam, S. (2007) Biological role of hepoxilins: upregulation of phospholipid hydroperoxide glutathione peroxidase as a cellular response to oxidative stressProstaglandins Leukot. Essent. Fatty Acids 77, 209-215